On Thursday, Bank of America Corp (NYSE:BAC)’s shares declined -1.73% to $17.32.
BAC has 62.90% institutional ownership while its EPS ratio was 1.35. The company has 10.41 billion shares outstanding while market capitalization of the company was $183.47 billion. Price to book ratio was 0.77. Net profit margin of the company was 30.40%. Stock volatility for the month was booked as 1.74% while for the week was recorded as 1.81%. The mean estimate for the short term price target for Bank of America Corp (NYSE:BAC) stands at $18.73 according to 28 Analysts. The higher price target estimate for the stock has been calculated at $20.00 while the lower price target estimate is at $16.00. Bank of America Corp (NYSE:BAC) is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers, small- and middle-market businesses, institutional investors, corporations and Governments with a range of banking, investing, asset management and other financial and risk management products and services.
Kinder Morgan Inc NYSE:KMI)’s shares dropped -6.78% to $19.26.
KMI has the market capitalization of $46.10 billion. The stock has P/B ratio of 1.19 while EPS was $0.52. Institutional ownership of the company was 55.90% while 2.23 billion shares were outstanding. Net profit margin of the Company was 7.30% while its gross profit margin was 52.80%. Share of the company moved below its SMA 50 with -29.20%. ROE ratio was 3.10% while ROI was 4.90%. The mean estimate for the short term price target for Kinder Morgan Inc NYSE:KMI) stands at $36.25 according to 16 Analysts. The higher price target estimate for the stock has been calculated at $45.00 while the lower price target estimate is at $28.00. Kinder Morgan Inc NYSE:KMI) is an energy infrastructure and energy company in North America. The Company operates through six segments: Natural Gas Pipelines, CO2, Terminals, Products Pipelines, Kinder Morgan Canada and Other. The Natural Gas Pipelines segment includes interstate and intrastate pipelines and its liquefied natural gas (LNG) terminals.
At the end of Thursday’s trade, OHR Pharmaceutical Inc (NASDAQ:OHRP)‘s shares surged dipped -3.54% to $4.09.
OHRP has market capitalization of $128.60 million. Its current ratio was 8.30 while its shares were above its 50 days simple moving average with 25.74%. The company offered earning per share of $-0.51 while its 30.33 million shares were outstanding. YTD performance of the company was -50.96%. Stock volatility for the week was 12.57% while for the month it was shown at 10.91%. The mean estimate for the short term price target for OHR Pharmaceutical Inc (NASDAQ:OHRP) stands at $19.50 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $30.00 while the lower price target estimate is at $3.00. OHR Pharmaceutical Inc (NASDAQ:OHRP) is a biotechnology company. The Company is engaged in the development of two products, OHR/AVR118 for the treatment of cancer cachexia (multi-symptom wasting disorder) and Squalamine for the treatment of the wet form of age-related macular degeneration (AMD) using an eye drop formulation.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.